Journal article
Upstream anticoagulation for patients with ST‐elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the TOTAL trial
Abstract
OBJECTIVES: To assess the relationship between preprocedural anticoagulation use and clinical and angiographic outcomes.
BACKGROUND: For patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI), the optimal timing of anticoagulant administration remains uncertain.
Authors
Cantor WJ; Lavi S; Džavík V; Cairns J; Cheema AN; Della Siega A; Moreno R; Stankovic G; Kedev S; Natarajan MK
Journal
Catheterization and Cardiovascular Interventions, Vol. 96, No. 3, pp. 519–525
Publisher
Wiley
Publication Date
9 2020
DOI
10.1002/ccd.28540
ISSN
1522-1946
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Administration, IntravenousAgedAnticoagulantsCoronary AngiographyDatabases, FactualDrug Administration ScheduleFemaleHeart FailureHumansMaleMiddle AgedPercutaneous Coronary InterventionRandomized Controlled Trials as TopicRecurrenceRisk AssessmentRisk FactorsST Elevation Myocardial InfarctionShock, CardiogenicStrokeTime FactorsTreatment Outcome